National drug safety program stalls in India; Counterfeiter re-sentenced, sent back to jail;

> Red tape has stalled the national pharmacovigilance program in India. Article

> A Chinese national has been re-sentenced to prison for misbranding and conspiring to distribute counterfeit drugs. Article

> Generic injectables maker Hospira has acquired the like-focused business of Orchid Chemicals & Pharmaceuticals. Release

> Owens & Minor now offers cGMP-compliant, third-party logistics and business-process outsourcing services to life sciences manufacturers. Release

> Through an agreement with Target Corp, Par Logistics Management offers a system to monitor and control reefer temperatures, react and respond to temperature alarms, and optimize logistics and management of cold chain assets. Announcement

Suggested Articles

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.

Branded drug sales in China could suffer in the short term as marketing activities for new meds are limited to reduce the risk of contagion.

Korean CDMO Samsung Biologics is expanding and China API maker WuXi STA opened a 30,000-square-foot oligonucleotide manufacturing facility.